914P The landscape of somatic copy number alterations of head and neck squamous cell carcinoma across different anatomic sitesSep 17, 2024 | Alberto Carral Maseda, Comunicaciones a congresos, ESMO
Real-world dosing patterns of regorafenib for patients with metastatic colorectal cancer in Spain: the RE-SEARCH studyAgo 11, 2024 | Alberto Carral Maseda, Publicaciones científicas
Rechallenge with Anti-EGFR Treatment in RAS/BRAF wt Metastatic Colorectal Cancer (mCRC) in Real Clinical Practice: Experience of the GITuD GroupMay 23, 2024 | Alberto Carral Maseda, Marta Covela Rúa, Publicaciones científicas
Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and databaseMay 20, 2024 | Alberto Carral Maseda, Publicaciones científicas
Real-world effectiveness and safety of trifluridine-tipiracil (FTD/TPI) and bevacizumab (BEV) in refractory metastatic colorectal cancer (mCRC): The BeTAS trial.Ene 22, 2024 | Alberto Carral Maseda, ASCO, Borja Gonzalez Gómez, Comunicaciones a congresos
Real-world effectiveness and safety of pembrolizumab in mismatch repair-deficient (dMMR) gastrointestinal non-colorectal tumors.Ene 22, 2024 | Alberto Carral Maseda
Kounis Syndrome During an Oxaliplatin Desensitization ProtocolDic 11, 2023 | Alberto Carral Maseda, Publicaciones científicas
P-277 Real-world efficacy, safety, and impact of the GIPI score of nivolumab in advanced esophageal squamous cell carcinoma (ESCC) refractory or intolerant to prior chemotherapy in European population: The EPIC trialJul 1, 2023 | Alberto Carral Maseda, Comunicaciones a congresos, ESMO
